bpc-157 human clinical trials safety fda status BPC-157: The peptide with big claims and scant evidence BPC-157: What you need to

Lee DG, Kim PI, Park Y, Jang SH, Park SC, Woo ER, et al

Research published in the Journal of Investigative Dermatology demonstrated that copper peptide application increased perifollicular blood vessel density by 58% compared to vehicle control in murine models

This drug belongs to a class of drugs known as GLP-1 (glucagon-like peptide-1), which works by mimicking the effects of the hormone GLP-1 in the body

Free from Unnecessary Additives No harmful preservatives or artificial ingredients

Tremor, Hyperreflexia, Myoclonus, Shivering LOOK In patients presenting in the context of an increased dose, overdose or suspected drug interaction involving any serotonergic agent, serotonin syndrome is likely if any of the following are found: Spontaneous clonus Tremor WITH hyperreflexia Ocular or inducible clonus AND agitation, sweating or hypertonia WITH fever Think of other differentials Other toxidromes: e.g